SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009817
Filing Date
2018-04-30
Accepted
2018-04-30 16:01:40
Documents
8
Period of Report
2018-06-19
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A scph-def14a_20180619.htm DEF 14A 860944
2 GRAPHIC g2018042700075059622920.jpg GRAPHIC 4518
3 GRAPHIC g2018042700075658322921.jpg GRAPHIC 78838
4 GRAPHIC g2018042700075050722919.jpg GRAPHIC 4518
5 GRAPHIC g2018042700075031622917.jpg GRAPHIC 4518
6 GRAPHIC g2018042700075661422922.jpg GRAPHIC 50083
7 GRAPHIC g2018042700075050022918.jpg GRAPHIC 4042
8 GRAPHIC g2018042700075031322916.jpg GRAPHIC 4042
  Complete submission text file 0001564590-18-009817.txt   1070474
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38293 | Film No.: 18789559
SIC: 2834 Pharmaceutical Preparations